VerifiedMedical Device· Founded 2015

Camereyes

Diabetes is the biggest 21st century epidemic with 400 million patients worldwide. One third of the diabetic patients is expected to suffer from Diabetic Retinopathy which is the leading cause for blindness within working age adults. Early diagnosis, and proper management of retinal diseases through fundus imaging can save people’s eyesight and reduce vision loss by up to 90%. Cameryes is building an online, easy to use screening solution for Diabetic Retinopathy that can be used by primary care providers to improve management of Diabetes patients and prevent blindness.

7-day free trial · no credit card

HeadquartersIsraelEmployees1 to 10Founded year2015Websitecamereyes.comLinkedIn profileLinkedIn

Verified contacts

1

available on Kipplo

LinkedIn employees

1 to 10

headcount range

Open roles

no listings

Distinct roles

1

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 1 verified contacts at Camereyes

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

1 contacts with verified email or phone · masked until revealed.

Sign up free →

No verified contacts on record for this company yet.

Top roles at Camereyes

1 distinct titles indexed · top 1 shown.

  • 1ceo

Sign up to unlock all 1 contacts at Camereyes

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 1 verified contacts at Camereyes

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Camereyes | Kipplo Discover